Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558

Trial Profile

Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Bortezomib (Primary) ; Mycophenolate mofetil (Primary)
  • Indications Systemic scleroderma
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Jan 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
    • 21 Mar 2016 Planned End Date changed from 1 Apr 2017 to 1 Nov 2017, according to ClinicalTrials.gov record.
    • 21 Mar 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Nov 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top